Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Omslag van het boek

2021 | OriginalPaper | Hoofdstuk

127. Gastro-oesofageale reflux bij kinderen van 0–18 maanden

Auteur : Gertrude van den Brink

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Gastro-oesofageale reflux (GORR) wordt gedefinieerd als de terugvloed van maaginhoud in de slokdarm, vaak met regurgitatie. Reflux is een normaal fysiologisch proces dat meerdere keren per dag optreedt bij gezonde kinderen van alle leeftijden, meestal na de maaltijd. Van gastro-oesofageale refluxziekte (GORZ, GOR mét klachten) wordt gesproken wanneer GOR leidt tot hinderlijke klachten met invloed op het dagelijks leven en/of complicaties zoals prikkelbaar gedrag, voedselweigering, groeivertraging, het opgeven van bloedsliertjes, slaapproblemen, luchtwegklachten of ‘apparent life-threatening events’.
Literatuur
1.
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., et al. (2018). Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for pediatric gastroenterology, hepatology, and nutrition and the European Society for pediatric gastroenterology, hepatology, and nutrition. Journal of Pediatric Gastroenterology and Nutrition, 66(3), 516–554.CrossRef
2.
3.
Davies, I., Burman-Roy, S., Murphy, M. S., Guideline Development G. (2015). Gastro-oesophageal reflux disease in children: NICE guidance. BMJ, 350, g7703.
4.
Bardou, M., Fortinsky, K. J., Chapelle, N., Luu, M., & Barkun, A. (2019). An update on the latest chemical therapies for reflux esophagitis in children. Expert Opinion on Pharmacotherapy, 20(2), 231–239.CrossRef
5.
Kwok, T. C., Ojha, S., & Dorling, J. (2017). Feed thickener for infants up to six months of age with gastro-oesophageal reflux. Cochrane Database of Systematic Reviews, 12, CD003211.
6.
Tighe, M., Afzal, N. A., Bevan, A., Hayen, A., Munro, A., & Beattie, R. M. (2014). Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database of Systmatic Reviews, (11), CD008550.
7.
Vandenplas, Y., & Hauser, B. (2015). An updated review on gastro-esophageal reflux in pediatrics. Expert Review of Gastroenterology & Hepatology, 9(12), 1511–1521.CrossRef
8.
El-Mahdy, M. A., Mansoor, F. A., & Jadcherla, S. R. (2017). Pharmacological management of gastroesophageal reflux disease in infants: current opinions. Current Opinion in Pharmacology, 37, 112–117.CrossRef
9.
Singendonk, M., Goudswaard, E., Langendam, M., Van Wijk, M., Van Etten-Jamaludin, F., Benninga, M., et al. (2019). Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children: A Systematic Review. Journal of Pediatric Gastroenterology and Nutrition, 68(6), 811–817.CrossRef
10.
Curien-Chotard, M., & Jantchou, P. (2020). Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort. BMC Pediatrics, 20(1), 152.CrossRef
11.
Singendonk, M. M. J., Brink, A. J., Steutel, N. F., Van Etten-Jamaludin, F. S., Van Wijk, M. P., Benninga, M. A., et al. (2017). Variations in definitions and outcome measures in gastroesophageal reflux disease: A systematic review. Pediatrics, 140(2), e20164166.
12.
Martigne, L., Delaage, P. H., Thomas-Delecourt, F., Bonnelye, G., Barthelemy, P., & Gottrand, F. (2012). Prevalence and management of gastroesophageal reflux disease in children and adolescents: A nationwide cross-sectional observational study. European Journal of Pediatrics, 171(12), 1767–1773.CrossRef
13.
Nielen, M. M. J., Spronk, I., Davids, R., Zwaanswijk, M., Verheij, R. A., & Korevaar, J. C. (2015–2016). Incidentie en prevalentie van gezondheidsproblemen in de Nederlandse huisartsenpraktijk in 2014: NIVEL Zorgregistraties eerste lijn [internet]. NIVEL. www.​nivel.​nl/​node/​4309, geraadpleegd april 2016.
14.
Loots, C., Kritas, S., Van Wijk, M., McCall, L., Peeters, L., Lewindon, P., et al. (2014). Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. Journal of Pediatric Gastroenterology and Nutrition, 59(2), 237–243.CrossRef
15.
Salvatore, S., Savino, F., Singendonk, M., Tabbers, M., Benninga, M. A., Staiano, A., et al. (2018). Thickened infant formula: What to know. Nutrition, 49, 51–56.CrossRef
16.
Duncan, D. R., Larson, K., & Rosen, R. L. (2019). Clinical aspects of thickeners for pediatric gastroesophageal reflux and oropharyngeal dysphagia. Current Gastroenterology Reports, 21(7), 30.CrossRef
17.
Van der Pol, R., Langendam, M., Benninga, M., Van Wijk, M., & Tabbers, M. (2014). Efficacy and safety of histamine-2 receptor antagonists. JAMA Pediatrics, 168(10), 947–954.CrossRef
18.
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. The American Journal of Gastroenterology, 108(3), 308–328; quiz 29.
19.
Baldassarre, M. E., Di Mauro, A., Pignatelli, M. C., Fanelli, M., Salvatore, S., Di Nardo, G., et al. (2019). Magnesium alginate in gastro-esophageal reflux: A randomized multicenter cross-over study in infants. International Journal of Environmental Research and Public Health, 17(1), 83.CrossRef
20.
Ummarino, D., Miele, E., Martinelli, M., Scarpato, E., Crocetto, F., Sciorio, E., et al. (2015). Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants. Journal of Pediatric Gastroenterology and Nutrition, 60(2), 230–235.CrossRef
21.
Miller, S. (1999). Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Current Medical Research and Opinion, 15(3), 160–168.CrossRef
22.
Cucchiara, S., Gobio-Casali, L., Balli, F., Magazzu, G., Staiano, A., Astolfi, R., et al. (1989). Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. Journal of Pediatric Gastroenterology and Nutrition, 8(2), 150–156.CrossRef
23.
Simeone, D., Caria, M. C., Miele, E., & Staiano, A. (1997). Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. Journal of Pediatric Gastroenterology and Nutrition, 25(1), 51–55.CrossRef
24.
Cucchiara, S., Staiano, A., Romaniello, G., Capobianco, S., & Auricchio, S. (1984). Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Archives of Disease in Childhood, 59(9), 842–847.CrossRef
25.
Naeimi, M., Kianifar, H., Memariani, Z., Kamalinejad, M., Bijani, A., Saghebi, R., et al. (2019). Comparison of the efficacy of ranitidine and quince syrup on gastroesophageal reflux disease in children. Complementary Therapies in Medicine, 45, 215–221.CrossRef
26.
Houben, E., Johansson, S., Nagy, P., Penning-van Beest, F. J. A., Kuipers, E. J., & Herings, R. M. C. (2018). Observational cohort study: Safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists. Current Medical Research and Opinion, 34(4), 577–583.CrossRef
27.
Hussain, S., Kierkus, J., Hu, P., Hoffman, D., Lekich, R., Sloan, S., et al. (2014). Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD. Journal of Pediatric Gastroenterology and Nutrition, 58(2), 226–236.CrossRef
28.
Moore, D. J., Tao, B. S., Lines, D. R., Hirte, C., Heddle, M. L., & Davidson, G. P. (2003). Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. Journal of Pediatrics, 143(2), 219–223.CrossRef
29.
Orenstein, S. R., Hassall, E., Furmaga-Jablonska, W., Atkinson, S., & Raanan, M. (2009). Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. Journal of Pediatrics, 154(4), 514–520 e4.
30.
Winter, H., Gunasekaran, T., Tolia, V., Gottrand, F., Barker, P. N., & Illueca, M. (2015). Esomeprazole for the treatment of GERD in infants ages 1–11 months. Journal of Pediatric Gastroenterology and Nutrition, 60(Suppl 1), S9–S15.CrossRef
31.
Winter, H., Kum-Nji, P., Mahomedy, S. H., Kierkus, J., Hinz, M., Li, H., et al. (2010). Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1–11 months old with symptomatic GERD. Journal of Pediatric Gastroenterology and Nutrition, 50(6), 609–618.CrossRef
32.
Gieruszczak-Bialek, D., Konarska, Z., Skorka, A., Vandenplas, Y., & Szajewska, H. (2015). No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials. Journal of Pediatrics, 166(3), 767–770 e3.
33.
Zohalinezhad, M. E., Imanieh, M. H., Samani, S. M., Mohagheghzadeh, A., Dehghani, S. M., Haghighat, M., et al. (2015). Effects of Quince syrup on clinical symptoms of children with symptomatic gastroesophageal reflux disease: A double-blind randomized controlled clinical trial. Complementary Therapies in Clinical Practice, 21(4), 268–276.CrossRef
34.
Ummarino, D., Miele, E., Masi, P., Tramontano, A., Staiano, A., & Vandenplas, Y. (2012). Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children. Diseases of the Esophagus, 25(8), 671–677.CrossRef
35.
Cucchiara, S., Minella, R., Iervolino, C., Franco, M. T., Campanozzi, A., Franceschi, M., et al. (1993). Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Archives of Disease in Childhood, 69(6), 655–659.CrossRef
36.
Azizollahi, H. R., & Rafeey, M. (2016). Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants. Korean Journal of Pediatrics, 59(5), 226–230.CrossRef
37.
Ruigomez, A., Johansson, S., Nagy, P., & Garcia Rodriguez, L. A. (2017). Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study. Current Medical Research and Opinion, 33(12), 2201–2209.CrossRef
38.
Van Ginderdeuren, F., Kerckhofs, E., Deneyer, M., Vanlaethem, S., & Vandenplas, Y. (2015). Influence of respiratory physiotherapy on gastro-oesophageal reflux in infants: A systematic review. Pediatric Pulmonology, 50(9), 936–944.CrossRef
Metagegevens
Titel
Gastro-oesofageale reflux bij kinderen van 0–18 maanden
Auteur
Gertrude van den Brink
Copyright
2021
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2739-3_127